Shares of Essex Property Trust, Inc. (NYSE: ESS ) have been a solid performer over the past year, adding 29% as limited supply in its California markets have enabled higher rental inflation than elsewhere in the nation. GoodOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!Analyst’s Dis ...

ESS's CEO, Eric Dresselhuys (center, wearing a blue jacket), taking a group of reporters on a tour ... [+] of the company's Energy Warehouse product for commercial and industrial customers and for mini-grid back-up power. The Energy Warehouses (the container seen on the right) contain iron redox flow batteries.ESS Tech, Inc.ESS Tech, Inc. (NYSE: GWH) is a Wilsonville, Oregon developer and manufacturer of iron redox flow batteries and a contender in the battle for the emerging long-duration energy storage ma ...

Essex Property Trust, Inc. (NYSE:ESS) Q4 2024 Results Conference Call February 5, 2025 12:00 PM ET Company Participants Angela Kleiman - President, CEO Barb Pak - EVP, CFO Rylan Burns - EVP, Chief Investment Officer Conference Call Participants Nick Yulico - Scotiabank Eric Wolfe - Citibank Austin Wurschmidt - KeyBanc Capital Markets Steve Sakwa - Evercore ISI Jeff Spector - Bank of America Jamie Feldman - Wells Fargo Brad Heffern - RBC Capital Markets Adam Kramer - Morgan Stanley Alexander Goldfarb - Piper ...

Essex Property Trust Inc. (ESS) reported fourth-quarter 2024 core funds from operations (FFO) per share of $3.92, beating the Zacks Consensus Estimate of $3.90. The figure also improved 2.3% from the year-ago quarter.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Results reflect favorable growth in same-property revenues and net operating income (NOI). ESS issued first-quarter and full-year 2025 guidance for core FFO per share.Total revenues of $454.5 million outpaced the Zacks Con ...

For the quarter ended December 2024, Essex Property Trust (ESS) reported revenue of $454.47 million, up 7.8% over the same period last year. EPS came in at $3.92, compared to $1.02 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $453.08 million, representing a surprise of +0.31%. The company delivered an EPS surprise of +0.51%, with the consensus EPS estimate being $3.90.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...

Essex Property Trust (ESS) came out with quarterly funds from operations (FFO) of $3.92 per share, beating the Zacks Consensus Estimate of $3.90 per share. This compares to FFO of $3.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of 0.51%. A quarter ago, it was expected that this real estate investment trust would post FFO of $3.88 per share when it actually produced FFO of $3.91, delivering a surprise of 0.77%.Over the last four ...

Exhibit 99.1 FOURTH QUARTER 2024 EARNINGS RELEASE & SUPPLEMENTAL DATA Beaumont | Woodinville, WA Fourth Quarter 2024 Earnings Release and Supplemental Data | Table of Contents | | | --- | --- | | Earnings Press Release | Pages 1 - 8 | | Consolidated Operating Results | S-1 & S-2 | | Consolidated Funds from Operations | S-3 | | Consolidated Balance Sheets | S-4 | | Debt Summary | S-5 | | Capitalization Data, Public Bond Covenants, Credit Ratings and Selected Credit Ratios | S-6 | | Portfolio Summary by Count ...

SAN DIEGO, Jan. 27, 2025 /PRNewswire/ -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023 and October 31, 2024. ESSA is a clinical stage pharmaceutical company that focuses on the development of small molecule drugs for the treatment of prostate cancer. The Company's lead product candidate was masofaniten, which was in clinical trial in combination with e ...

Essex Property Trust (ESS) shares rallied 4.1% in the last trading session to close at $282.95. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.3% loss over the past four weeks.The increased investor optimism in the stock can be attributed to the recent announcement from BMO Capital Markets, where its research analyst upgraded the ESS rating to “Outperform” from “Market Perform.”This real estate investment ...

Essex Property Trust, Inc. (ESS) is well-poised to gain from a robust property base in the West Coast market with several demand drivers. Efforts to leverage technology, scale and organizational capabilities are expected to drive margin expansion. A healthy balance sheet augurs well. Solid dividends aid shareholder wealth.However, the rising supply of apartment units in some of the company’s markets is likely to fuel competition and curb pricing power. A concentrated portfolio and substantial debt burden re ...